Hardman & Co Research: Deepbridge Life Sciences EIS - Deepbridge Capital LLP
The Deepbridge Life Sciences EIS is an alternative investment fund focused on investing in a portfolio of life science-focused companies across a variety of areas. The target return is £1.70 for each £1 invested (gross) in four to five years. There is no income target.Deepbridge has been the manager since early 2021. Prior to that, it was the fund advisor, with Enterprise Investment Partners as the manager.
The report goes into details of how the investment process works, sourcing and decision-making, exit strategies, post-investment governance and monitoring, fees and more. It also includes Hardman & Co’s unique fee calculation table, allowing advisors and investors to properly investigate their effect.
We are a rapidly growing, innovative corporate research & consultancy business, based in London, serving the needs of both public and private companies.
Our expert team of sector analysts and market professionals collectively have over 400 years of experience. This depth of knowledge and a reputation for integrity have built trust with investors. With effective communication and precision distribution, we help companies disseminate their investment message to interested investors, as well as advise them on strategy.
Our smaller, boutique structure allows us to provide first-class customer service and to deliver a wide range of ad-hoc services for multiple clients with different needs.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.